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Cardiac rehabilitation consists of oxcrclse, psyrhowdal sup- 
port and education and is prescribed most oftoo for patients with 
coronary heart disease. Its purpme is to facilitate readoptantioa Lo 
norma! life through the achiewnent of maximal Iunction~l capa- 
bility and to reduce heortdtseox risk fociors. llbegao historicolly 
with progressive nmhulotion after myoeordlrd lofarctlon and by 
;!I69 ixume a standardized inpotieot ihempy performed oecord- 
tog to o stepped procedure. Predisckrge exercise tesli~g was 
addedaod has kanea meaningful contribulion to thrconceptof 
risk stratification aller an acute cnrwary event. Rehabilitation 
bari subsequently bewme pal OF the outpatient environment and 
is delivered by multiple models. hSeta-analyses hove shorn that 
rehabiliWion reduces overnll and emrdlovosculnr deotbs hy oboul 
20% and sudden death by about 37% during the year oftcr oo 
acute myoatrdial infarction. The signilicance of this, however, 
must now be ox&dated by the dynaode role of aggressive 
coronary intervention. Selection for stub in*rvenW has become 
an impnrirml ndjunctive aspect of rehabilitalian. Newer %dings 
rug@ lhat those stratilied at low risk will kmt% mosl by the 
modifieollon of comonry elsk focforr, and that patknts pwiously 
thought to he pwr candiaies for rehabilitation (slleh as those 
wtth signtftcant left veotriculor dysfunction and low work ups 
tty) may exp&oce substootiol relative fooetioool benefit. Beyond 
rtsk strotifieotioo, importooteootemporory issues toelode soneil- 
Iaoee of patients after ongtoplasty, lhe elfativenas of rehobitito- 
lioo in the ottenoatioo or reversal of both ootive and vein gndt 
otherosclercmia sod mmiderotion of aocb currently empboeized 
end points as quality d life and e evaluaiieu. 
(1 Am Call CamM 1993:21:822-34) 
In the minds of many cardiologists, cardiac rehabilitation is 
suborcinstcd to more aggressive cardiovascular therapeu- 
tics. flistoricallv. rehabilitation derived from the concert of 
early mobilizatibn after acute myocardial infarction. This led 
to the belief that the primary purpose of rehabilitation was 
exercise conditioning. The aim of this review is to trace the 
evolution ofthe technique and explain how it has evolved far 
beyond exercise conditioning to include risk stratification, 
quality of life and life-style modification. Cardiac rehabilita- 
tion, through its effects on the dynamics of cardiovascular 
function and on coronary disease risk factors, is integral to 
the treatment of most cardiac conditions and should accom- 
xxy other contemporary modes of cardiac therapy. 
Milestones of the Past 
Early moblliaation after myneardlal InfarctIon. After the 
clinical description of myocardial infarction by Herrick in 
1912. oatients were eenerallv confined to bed rest for 2 
monihb. The fear wasihat phy&al activity would lead to the 
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formation of ventricular aneurysm, heart failure, cardiac 
rupture and sudden death (I). 
In the late 193Os, Maltory and associates (2) described the 
pathologic evolution of myocardial infarction as a process 
maturing over 6 weeks from initial ischemic necrosis to 
formation of a stable scar. This time characterization of 
infarct evolution reinforced the prevailing clinical practice of 
strict bed rest for 6 to 8 weeks after acute myocardial 
infarction. Activities defined as strenuous, such as stair 
climbing, were restricted for protracted periods, sometimes 
indefinitely. Return to a normal lifestyle, including resump 
tion of gainful employment, was rare. 
By the late WiOs, studies that questioned the ellicacy of 
prolonged bed rest appeared (3,4). Levine and Lown ($6) 
advocated the use of chair thsrapy as an alternative to 
prolonged bed rest. The proposed rationale was that the 
dependency of the lower limbs led IO reduced venous return, 
a decreased stroke volume and a reduction of cardiac work. 
The belief of these investigators that sitting decreased car- 
diac work was slightly erroneous because this position 
results in a smailer increase in oxygen consumption than 
does the supine position. However, this added energy re- 
quirement is minimal and is more than offset by the advan- 
tages of early mobilization. Nevertheless, the chair therapy 
of Levine and LOW was one of rhe first departures from rhe 
oracticc of strict bed rest. 
Newman and coworkers (7) defined early ambulation as 
3 to 5 min of walking twice da.ly beginning 4 weeks after 
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infarction. Brummer and colleagues in 1956 (8) wore among 
the first to report on the use of early ambulation within 14 
days of the acute event. In l%l Cain and associates (8al 
reported on the efficacy and sachet) of an early graded activity 
program. Thereafter, clinicians gradually became aware that 
early mobilization might not be hanlful and. in fact, could 
avoid some of the complications of bed rest. such as pulmo- 
nary embolism and dccondltioning (9). Subsequent studies 
have shown that the adverse hemodynamic effects of bed 
rest are rel&ed ts the :is~p;,izati;n cf the ni;rnx! :p:ieh: 
response to grawty (IO) and are not related to alterations in 
sympathetic or pressor responses (I 11 or to muscular decon- 
ditioniog as such. 
Cotneidcnt shortening of hospital stay. By the late I96lls. 
3 weeks of hospitalization after myocardial infarction was 
routine in the U.S. The early 1970s aw a fturry of research 
related to early mobilization. particularly in England and in 
countries where the cost of hospitalization had already 
become a major social welfare issue. Croden et al. (9) and 
athers (12,13) demonstrated the similarity in the outcome 
and safety of early ambulation therapy, but the studies were 
not prospective or randomized. Controfted :!udies of early 
ambulation by Boyle and Lorimer (14) and others (15-17) 
revealed no significant difference in the occurrence of an- 
gina, reinfarction, heart failure or death. Bloch et al. (16) 
found greater disability up to I year later in patients who had 
not had early mobilization. 
Abraham and colleagues (17) found that early ambulation 
was benet?cial regardless of complications such as angina or 
congestive heart failure during the early infarction period: 
they also found that morbidity and mortality were much 
higher in patients v,ith a complicated than in those with an 
uncomplicated course (I). The most important clinical pre- 
dictors for complications were prior myocardial infarction 
and congestive heart failure or cardiogenic shack (I). It is 
now believed that ambulation should be deferred in these 
patients until they have been stabilized medically and then 
increased gradually ur.der close observation (IRI. Table I 
summarizes criteria for later classification of patients at low. 
intermediate or high risk. 
As early ambulation was increasingly applied, it evolved 
into what we currently define as phase 1 or inpatient cardiac 
rehabilitation (19). Wenger et al. (19) did much to systemize 
the technique and to promote it for clinical use. Activities 
performed in the coronary intensive care unit were limited to 
2 METS. The MET (metabolic equivalent) describes total 
oxygen requirements by the body (I MET = 3.5 ml 0, 
consumedikg body weight per min). In general, METS FOP 
relate with myocardial oxygen demand, but the relation 
varies according to the type of activity. Upper limb activities 
orisometric activities may invoke nigher myocardial oxygen 
demands than do lower limb activities Activities that re- 
quire fewer than 2 METS include self-care activities, such a- 
bed bathing, use of a bedside commode, chair sitting and 
passive and active range of motion. This portion of the 
Table I. Characteristics of Low. InternwJiatc aad High 
Risk Patients 
experience usually is supervised by the uni: nursing staffbut 
sometimes involves a specialized rehabilitation team (20). 
Formalization of phase I. Once transferred from the car- 
onary cue unit, the rehabilitation specialists usually super- 
vise the activity regimen. They may be nurses, physical or 
occupational therapists or exercise physiologists with spe- 
cial training and experience (20). Surveillance of the re- 
sponre to early ambulation is facilitated by the use of 
telemetered electrocardiographic (ECGI monitoring (19). 
Untoward responses to activity include dyspnea, ischemic 
chest pain, arthythmia or a disproponionate heart rate 
response to exercise (21). ST segment abnormalities during 
ambulation by nonstandardized telemetry monitoring may 
be misleading and require conlim~ation by 12-lead ECG 
recordings. The postexercise heart rate should remain within 
20 beatsimin of the rate at rest. and blood pressure should be 
within 20 mm Hg (II. A decrease in systolic blood pressure 
of z 15 mm Hg below the baseline value at rest is worrisome. 
The inability ID maintain or increase systoiic pressure with a 
low work load suggests compromised pump function that 
may reflect either extensive intrinsic damage or large 
amounts of myocardium u..der ischemic stress. Any one of 
these findings warrants clinical reassessment. An appropri- 
ate response ID a given level of activity indicates that the 
patient can be advanced safely to activities of greater inten- 
sity (19). 
The major goal for the physical activity portion of the 
phase I program is to condition the patient for the exertional 
demands required after discharge (22). This is a reasonable 
task because most acrivCies of daily living in the home 
environment require less than 4 METS. St&climbing should 
be monimred and supervised until competency and safety 
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Exercise Testing Clinical Course 
are confirmed. Historically. activity was prescribed in rather 
rigid steps, and the MET Ieve: of each step was tied closely 
to the time elapsed after the event. Several early ambulation 
protocols defining from 7 to 14 steps are available (I ,211. The 
exercises prescribed were correlated with various activities 
of daily living and educational and recreational aclivities. 
Currently we advocate il&idualized exercise therapy by 
supervising progress closely with appropriate altemtions in 
exercise frequency, time and distance. Because progress 
occurs in fractions of a MET and because patients may be 
fatigued from concurrent medical procedures or other activ- 
ities, individualization seems suitable. Defined activity for- 
matsare useful where cardiac rehabilitation is not performed 
by specialists. Such formats provide an activities template 
and eliminate the need to write specific daily activity orders 
for every patienl (21). 
safety, as well as its ability to predict the risk of occurrence 
of angina, recurrent myocardial infarction and death after 
infarction (28-30). Early exercise testing contributed to the 
developing concept of risk stratification and the recognition 
of the need for further intervention. As outpatient rehabili- 
tatiort prograns have come into being, the graded exercise 
test, even when performed before discharge, has become a 
prerequisite first step. 
With time. the limits of activity have beeo extended 
safely, and from the mid-1970s to the mid-19805, the length 
of hospital stay was shortened from 14 to approximately IO 
days (23,124). Currently, length of stay for uncomplicated 
infarction in the U.S. is 6 to 7 days. This reduction has 
significant implicstions for outpatient rehabilitation pro- 
grams. 
Originally, exercise tests were performed to a leve! that 
approximated thedegree of physical activity achieved during 
the latter days of hospitalization and were stopped on the 
basis of fixed end points. usually by heart rate or MET level 
(27). Even earlv studies showed that selected uatients can be 
tesied safely to symptom- or sign-limited end’points (28.3 I). 
Currently, a heart rate of 130 beats/mitt or 5 METS is us:d 
for patients >40 years old, and 140 beats/mitt or 7 METS is 
used for patients ~40 years old. A perceived exertion level 
(32) of 7 of IO (new scale) or 15 of 17 (old scale) can also be 
used to end the test. 
Risk Stratification After 
Myocardial Infarction 
Evelution of risk stratilica~ion. Three factors virtually 
determine the prognosis of any patient after myocardial 
infarction: the amount of residual myocardium at risk, the 
extent of left ventricular dysfunction and the at-rhythmic 
potential of the cardiac substrate. Predischzrge risk stratih- 
cation is iniended to recognize persons at risk for death or 
reinfarction and those at low risk who need only conven- 
tional therapy to achieve a good prognosis (33). 
Predischarge exercise testing. Exercise testing is impor- During the 1980s. therapies for particular subsets of 
tant in assessing the status of patients who recover from an patients improved the survival rate aHer acute myo-cardial 
acute myocardial infar&tt (25). It is especially useful for infarction (34). Predischarge exercise ECG testing may help 
assessing and reassuring patients about their ability to return identify those patients who might experience ischemically 
16 work and mrnal recreational activities (22). Early studies mediated events. such as subsequent infarction, and who are 
(26.27) of exercise testing demonstrated the feasibility and ca-didates for more aggressive interventions such as sttrgi- 
cal revascularitation (35). Figure I elaborates a simple 
scheme for risk stratification after myocardial infarction. 
Top01 et al. (36) established that submitting patients who 
are recovering from an acute infarction to exercise testmg 
actually may cxpedile and optimize theu discharge from lhe 
hospital. Early submaximal exercise testing is usei in 
evaluating patients with unstable angina for the presence of 
multivessel coronary artery disease after their condition has 
stabilized (371. 
Predischarge low level exercise testing predicted subse- 
quent events better tban a ~ubmaxitttal :es: pescrmed sf!cr 
myccardial infarction at 6 weeks. Almost 207~ of patients 
tested early were unab!e to undergo testing 6 weeks after- 
ward because of recurrent ischemia. infarction or death (38). 
Krcne and colleagues (39) conftrm that just performing a 
predischarge study is associated with a 10% lower mortality 
rate and a lower incidence of subsequent ccrcnary events. 
but they imply tbat low level exercise testing is most useful 
in patients who exhibit other clinical markers of higher ris!;. 
A trend toward earlier higher level testing is somewhat at 
odds with our understanding of the pathophysiology of 
myocardial infarction. The duration of the healing phase is 
about 6 weeks. Traditionally, we have assumed that a heart 
subjected to amajcr increase in rate or blood pressure during 
this period will experience deleterious elfects. The hypothet- 
ical hazards of exertion in patients with myocardial infarc- 
tion are cardiac rupture, aneurysm formation. extension of 
infarction, congestive heart failure an3 serious arrhythmias 
(22). in practice. these problems are rarely reported in 
patients who perform moderately intense exercise I or 2 
weeks after infarction. However. for purposes of risk strat- 
ification. the point is that abnormal responses at higher work 
loads are not as predictive as those at lower work loads (40). 
The ellicacy of cliniti judgment. Clinical judgment can 
also identify high risk patients (4l), and ST segment shifts 
are not as predictive of high risk as an abnormal systolic 
blood pressure response or poor exercise capacity (40). 
When Frcelicher and his colleagues (40) subgrouped the 
studies by time of testing (before discharge or after dis- 
charge). a high proportion of test results before discharge 
were accurate predictors of a poor outcome. Risk predictors 
from exercise testing best identify the patients who die early 
after myocardial infarction before later testing can he done. 
This finding coincides with the observation that one third of 
the Ist-year mortality occurs within the 1st 6 weeks after the 
acute infarction (35). The process of risk stratification has 
become an integral part of the management of patients 
during and after an acute myocardia[ event regardless of 
whether rehabilitation s planned (33). 
Applying Ihe 6ndfngs of risk stratification. The rest&s of 
risk stratification provide signposts for patient management 
throughout the rehabilitative process (Table I). For exam- 
ple, a ptient with poor ventricular function, an abnormal 
signal-nvemged ECG and low exercise capacity preferably 
needs cardiac monitcGrg and exercise supcrvisxm in a 
hospital- or facility-based program. The patient is not a 
candidate. at lcast initially, for community-based group or 
unsupervised. unmonitored home rehabilitation. In contrast. 
a patient with an uncomplicated complete surgical revascu- 
larization can begin progressive aetivi;y in tbe home, un- 
dergc symptom-limited exercise testing when recovered 
surgically and continue exercising in a home- or community- 
based program. This patient may need some supervised 
training to ensure the appropriate understanding of the 
exercise prescription and for coronary risk factor education 
and modification. Levels of low, intermediate or high risk 
lie also useful for program planning. especially for st&ig 
and rescurce allocation (20) or for reimbursement of prc- 
gram serv,ces. such as ECG monitoring, according to cur- 
rent guidelines and standards (42). 
Risk stratification guidelii. On behalf of the Health and 
Public Policy Committee of the American College of Fhysi- 
cians. Greenland and Chu (43) recommended that interme- 
diate risk patiems be detiaed as those who experienced 
shock or congestive heart failure during a recent (within 6 
months) myocardial infarction. those who demonstrate 
<2 mm of ischemic ST segment depression or those who are 
unable to monitor their own activity or comply with the 
exercise prescription. They recommended for these patients 
a time-IimLed program rather than the typical full S- to 
12.week program. 
They (43) defined high r!sk patients as those who have 
severe depression of left ventricular function (ejection frac- 
tion ~3070): complex ventncular arrhfihmias at rest; ven- 
tricular arrhythmia that increases during exercise; a de- 
crease in systolic blnnd pressure 215 mm Hg with exercise; 
recent myocnrdii! infarction (within 6 months1 complicated 
bv serious arrhvthmias; survival of sudden cardiac arrest. or 
marked. e&se-m&red ischemia indicated by angina 
22 mm of ST depression, cn the ECG. Patients with these 
clinical features are appropriate candidates for ECG telem- 
etry monitoring during exercise. 
Guidelines for risk stratificatiop have been produced by 
other oreanizations as well. The American Association of 
Cardiov&ular and Pulmonary Rehabilitation published its 
guideiines in 1991 (42), which indicaie tile extettt of patient 
supervision and establish appropriate levels for service 
reimbursement. There are some major differences between 
the guidelines with regard to what markers discriminate, for 
:xample. between internme&% and high risk. Major differ- 
ences between the two risk stratification schemes include 
<?-mm ST segment depression as an intermediate risk in 
one (American College of Physicians) versus >2-mm ST 
depression as an intermediate risk in the other; a changing 
pattern of angina is included in one scheme as intermediate 
but not specifically addressed in the cther(American College 
of Physicians). The guidelines of the American Association 
of Cardiovascular and Pulmonary Rehabilitation also list 
combinations of iscbemic markers thought to be assocjared 
with increased risk: functional capacity ~5 METS with 
hypotensive blood pressure response or ?I-mm ST segment 
depression; or 22~mm ST segment depression at a peak 
heart rate of ~135 beats/min (42). 
Regardless of how the various schemas are defined, the 
responses that reflect ischemia during exercise testing in- 
clude noi just ST segment (ECG) changes but also global 
exercise capacity and the presence or absence of angina. 
Ventricular function is best retlected by the ability to main- 
tain an appropriate systolic blood pressure response and the 
accomplishrrsnt of adequate aggregate of work (41). Ar- 
rhythmic potential can be highly deceptive, but it is clearly a 
risk when sustained ventricular arrhythmia is present spon- 
taneously or can be induced in the electrophysiofogy or 
exercise laboratory (44). Table 1 is derived, in pan, from 
current guidelines, as well as from some of the newer means 
of identifying risk, and summarizes the characteristics of 
low, intermediate and high risk patienrs. Although low risk 
patients do not require ECG monitoring and close exercise 
supervision and intermediate risk patients may require only 
inlermittent ECG monitoring, high risk patients are being 
seen more often in cardiac rehabilitation programs. For this 
reason alone, the future of institution-based phase II exer- 
cise rehabilitation programs seems secure. 
Although there is no consensus as to the appropriate 
duration of monitoring needed for high risk patients, the 
preceding guidelines and the studies characterizing high risk 
patients suggest some means of appropriate allocation of the 
monitoring technology. Continuous monitoring is reasonable 
for high risk patients throughout their course of exercise 
therapy (43). After 8 to 12 weeks of such therapy with no 
adverse arrhythmia, patients who are otherwise in stable 
condition and are planning to continue exercise training can 
be monitored intermittently. Any destabilization of the un- 
derlying or related condition that may influenza the arrhyth- 
mic potentis!. such as decompensated heart failure, requires 
stopping the exercise regimen until the probkm is resolved 
and a stable rhythm is established, 
Beyond risk stratification guidebtes. Other factors, such 
as the presence of high frequency late potentials in the 
terminal portion of the QRS complex detected by signal 
averaging(45-47) or heart rate variability analyzed by power 
spectral analysis (48-51), have been identified as sensitive 
markers of risk for subsequent sudden cardiac death. These 
factors arc relevant to the rehabilitative process because 
they appear to be time dependent and may be modified by 
exercise conditioning (52). This may explain the reduced 
incidence of sudden death in patients who participate in 
exercise rehabilitation, as reported by O’Connor et al. (53). 
Figure 1 indicates how newer clinical technologies can be 
incorporated into risk stratification. Risk stratification needs 
to be an ongoing process. When patients were retested at 3 
months after myocardial infarction, signs of ischemia were 
important predictors of outcome, whereas indexes of ven- 
tricular function were more predictive in the predischar8e 
studies (54). 
Integraling education into cardiac rehabiiitation. Educa- 
tion about the cardiovascular disease process and inform+- 
tion intended for reassurance and psychosocial support also 
are key elements in cardiac rehabilitation. Historically. 
patient education in the form of one on one counseling began 
during the course ofroutine hospitalization and was added to 
the structured exercise. Although hospitalization for an 
acute coronary event usually gets the attention of patients, 
often they are so overwhelmed by the pain, confusion, fear 
and anxiety of the experience that not much information is 
retained. We suggest straightforward responses to patients’ 
questions in the early hours or days of the acute event 
followed by a more formal, structured educational process 
when the patient is further along in the physical and psycho- 
logic recovery. Repetition of key pans of the essential 
material is required to overcome emotional obstacles and is 
consistent with generally accepted learning theory. Studies 
suggest that such education can impmve quality of life 
(55,56). 
Growing impo~ce of datpatienl programs. With pro- 
gressive shortening rf the hospital stay, there is a greater 
need for structured outpatient rehabilitation programs in the 
home, hospital or community. The time spent in the hospital 
is not adequale to acquire the skills needed to monitor 
exercise activity or to wver the educational material ade- 
quately (57). 
Outpatient programs began to appear in the mid-1960s. 
To some degree, they represented a direct extension of 
phase I. Several alternative models were available from the 
beginning. Zohman (58) advocated that exercise be per- 
formed in phase I under close medical monitoring and 
supervision, and this esrablished a precedent that is followed 
today in many phase 11 formats in which continuous EC0 
monitoring and exercise supervision are both provided. 
Alternatively, gymnasium-based prograras with or wi;h- 
out intermittent ECG monitorina also became ~ooular f59- 
611. Data began to indicate thesignificant s&ty’of outpa- 
tient exercise rehabilitation regardless of the model followed 
(62). The gymnasium- or community-based programs were 
identified as phase 111 and were thought to be ideal for 
persons who had graduated from phase II programs. How- 
ever, by the late 197Os, patients with an uncomplicated 
course who were considered to be at low risk were being 
referred dircctlv. The conceot of risk stratification became 
more widely applied and was extended further in the mid- 
19Bos by DcBusk et al. (631, who advocated home exercise 
programs, especially for those believed to be at low risk. 
In what may be described as historical recapitulation, 
Fletcher and associates (64) proposed a stepped approach 
for outpatient exercise rehabilitation that takes into account 
patients’ risk stratification status and their measured exer- 
cise ability. By applying the basic principles of frequency 
and duration and specifically basing intensity and progres- 
sion on percent of ij&rnal oxygen uptake, their protocols 
are defined so that each patient entering exarcise training 
would gradually progress. The protocols consist of six phase 
II monitored levels designed to be completed within a 
minimum of six l-h sessions and six phase II nonmonitored 
levels designed fo be compIeted wilhin I2 weeks. After safe 
completion of both components, patients can be referred to 
IonPterm maintenance Dromdms. . I 
At home rehabilitation as a primary mode of therapy. 
DeBusk (63) and associates (65-67) at Stanford have studied 
at home exercise quite extensively. Their earlier reports 
focused on the effects of home-based exercise training on 
peak oxygen consumption in healthy. sedentary, middle- 
aged men and, later, women. One study showed that self- 
monitored, home-based exercise training of moderate Len- 
sity significanrly increased functional capacity in healthy, 
sedentary, middle-aged men and women (67). Moderate 
intensity training was performed five times a week in TO-min 
sessaons. Subiecls trained at 65% to 75% of maximal ore- 
dice: hem-I rate, and after 6 months oxygen uptake. in- 
creased by 15% in men and by about 10% in women. Such 
training provided a reasonable alrernative to groupbased 
exercise. The same group described the use of microproces- 
sors to track home-based exercise training and found it to be 
practical (65). 
They also compared medically directed at home rehabil- 
itation with group rehabilitation beginning 3 weeks alter 
uncomplicated acute myocardial infarction (63.66). Between 
3 and 26 weeks after infarction, adherence to individually 
prescribed exercise was equally high (aboul 7070). Ihe in- 
crease in functional capacity was similar (1.8 i I.0 METS) 
and nonfatal reinfarction and dropout rates were equally low 
(both 53%) in the subjects randamized to home or to group 
training. No training-related complications occurred in ei- 
ther group. DeBusk et al. (631 attribute the low rate of 
reintarction and death (5%and I%, respectively) m the study 
group to increased surveillance: a stepwise process of clir 
ical evaluation, exercise testing at 3 w&z and &quen! 
telephone contact of patients during the training period. 
Realities of the Present 
Chaagiog demcgraphks and the impaci ofaging. Both the 
absolute and relative proportions of the population who are 
older are increasing (68). This phenomenon is related 10 the 
current birth rate and IO Ihe decline in age-specific mortrdiry. 
Thus, we can expect an increase in the absoiule number of 
patients who have coronary disease (69), and these demo- 
graphic changes will inevitably have a huge impact on health 
care utilization and expenditures (701. 
The decline in cardiovascular deaths correlates with an 
increasing awareness and motivation to alter coronary dis- 
ease risk factors. Improved freatments and risk factor mod- 
ification through life-style change can reduce cardiovascular 
mortality (71,72). Because of rhe demographics of the in- 
creasing population, however, we must not misinterpret he 
decline in cardiovascular deaths to imply a lower future 
prevalence of disease, at least not in the next decade or two 
(69). !f anything, we should expect the prevalence of coro- 
nary heati disease to increase about 30% by the year 2015, 
even with 20% fo 25% decreases in case fatally and inci- 
dence rates 1691. 
U&erg and associates (73) documented rather striking 
chances in the demwrdnhic factors and the incidence of 
corn&bid conditions among patients admitted for acute 
myocardial infarction. They found that men constituted 7S% 
of the admissions to an urban hospital in I980 and only 43% 
of the admissions in 1988. The percentage of di&e!ic pa- 
tients ,ncreased fmm 27% in 1980 to 44% in 1988, and the 
diabetic patients were older on average than the nondiabcaic 
patients. The findings corrobomte our clinical experience 
that survivors of myocardial infarction today are older and 
sicker, and that this may be a future trend. 
The demographic haracteristics of those patients undcr- 
going surgical coronary revascularization are changing as 
well (74). The patients who undergo coronary bypass sur- 
gery are characteristically older, more commonly female, 
advanced in age and likely to have three-vesxl disease CT 
left ventricular dysfunctiw. At the Cleveland Clinic the 
percentap of patients who undergo bypass surgery who are 
~70 years old has risen from 0.2% in the p&d I%7 to 1970 
10 >3G% in 1989. More ihao 75% of procedures are now 
done for three-vessel disease. whereas i?% were performed 
between 1967 and 1970. Neariy MMC show some evidence of 
left ventricular dysfuncticn, whereas only 41% previously 
did (74). 
Percutaneous uanslnminai coronary angioplasty is sub- 
stantially changing the patient group that undergoes COT+ 
nary bypass ~gery. Patients who unde;eo coronary a&o- 
plasty are considerably younger (55 years vs. 68.5 years with 
38% 270 years old), and mosf have only one- or tw+vessel 
disease. The lefl ventricular ejection fraction in patients who 
undergo coronary bypass avemges 38%; the fraction for 
those undergoing coronary angioplasty is 55% (75). Patients 
who undergo surgery today are older, have more complex 
disease and have intrinsically poorer pump fun&n. 
Thompson (76) has observed that the increase in the 
number and proportion of elderly persons will create con- 
straints and pressures on ow resources and services, and 
this will probably be reflected in our actions and attitudes 
about aging and the elderly. He observes further that the role 
of the aging person is evolving from our stereotype of the 
retired or grandparent role lo a more active and panicipative 
one. The changing demographic profile compels us to antic- 
ipate newer approaches lo health care for an alder constitu- 
ency. Although the primary concern is the development and 
admicWation of a syslem of services for the chronically ill, 
these health services must be coordinated to meet a wide 
range of needs (76). 
Few data exist concerning the e@~acy ofcardiac rehabil- 
itation for the elderly patient. The need for such programs 
has been advocated 10 slow the age-related decline in car- 
diovascular function (77) and to lessen the functional impact 
of age-related changes superimposed on disease-induced 
cardiovascular disability (78). Bruce et al. (791 have shown 
that regular activity, such as walking, leading to condirioning 
wilf also lower relative aerobic costs of everyday activities 
and that physical training can lower functional aerobic age in 
men with coronary heart disease to that produced by suc- 
cessful coronary revascularization. Ades and Grunvald (SO) 
have shown in a nonrandomized study that the condition of 
elderly cardiac patients beginning at rclative!y lower level of 
fitness improved to the same degree as in younger patients. 
Gori et al. (81) found that poor compliance among elderly 
patients is most often related to medical problems and lack 
of motivation. Their participation in such programs is all the 
more important, however, because they are less capable 
physically, more dependent on others and have a smaller 
reserve than do younger patients. 
Rehabilitation end pot&. With the establishment of suc- 
cessful earlier ambulation after myocardial infarction. the 
belief emerged that exercise would improve prognosis. Ex- 
ercise is the fundamental element of cardiac rehabilitation 
programs, with the major focus on improving functional 
capacity and the contingent achievement of other important 
secondary goats. Major end points of rehabilitation outcome 
therefore include functional capacity, changes in psychoso- 
cial function, health education after acute irchemic event, 
morbidity and mortality, ventricular function, cardiac perfii- 
sion or collateral circulation and secondary risk factor 
modification (82). 
Tradilional measures of outcome-death, recurrent 
events, exercise improvement. M&+-analyses that reviewed 
randomized, prospective studies of cardiac rehabilitation 
versus usual care have confirmed its efficacy for the reduc- 
tion of death atIer heati attack (S3,83). Oldridge et al. (83) 
found that integrated programs of rehabilitation after myo- 
cardial infarction reduced mortality by 20% to 25%. Further- 
more, the e&cts on mortality were influenced markedly by 
continuing the program beyond the usual 8 to 12 weeks. A 
significant impact on subsequent nonfatal myocardial infarc- 
tion was not observed. In a meta-analysis of randomized trial 
of rehabilitation with exercise after myocardial infarction, 
O’Connor et al. (53) found reductions in cardiovascular 
mortality to be consistent with Oldridge’s findings (83) and 
also found a 37% reduction in the incidence of sudden 
cardiac death during the 1st year after the acute cardiac 
event. We feel this reduction in the rate of sudden death is 
mostly related to the presence of skilled supervision and the 
early appreciation of clinical destabilization during the reha- 
bilitation sessions, but the possibility that intrinsic changes 
may occur in the cardiac substrate or catecbolamine- 
mediated responses to exercise clearly exists (50,52). 
Despite Oldridge’s findings (83). some data show that a 
comprehensive cardiac rehabilitation program can reduce 
the incidence of subsequent infarctioa. This was demon- 
strated in a study of a nonselected intervention in patients 
who survived acute myocardial infarction and who were 
randomly assigned to a rehabilitation program that included 
follow-up study a1 a special postmyocardial infarction clinic, 
exercise training. the provision of information on smoking 
cessation and diet and psychologic support to patients and 
their families. During the j-year follow-up period, cardiac 
mortality did not differ between the groups, but the recur- 
rence rate of nonfatal myocardial infarction (17.3% vs. 
33.3%) and the rate of total cardiac emots were lower in the 
intervention group (39.5% vs. 53.2%)). This reduction may 
reflect an alteration of risk factors because there were fewer 
smokers and uncontrolled hypertensive patients in the inter- 
vention group. The program was particularly effective in 
those patients 455 years old who had significantly fewer 
cardiac events and who returned to work more ofien than 
members of the reference group (S4). Again, the issue here 
may be related to the increased supervision inherent in a 
rehabilitation program and the ability to detect early desta- 
bili?ation. 
Several studies (82) have documented improvement in 
exercise capacity with training by an average of 15% to 25%. 
Others studies have suggested, however, that patients will 
self-condition to adequate levels without formal exercise 
training (85). but that the rapidity of conditioning may be 
improved considerably. Investigators suggest that phase I 
rehabilitation in uncomplicated, low risk patients eliminates 
the need for phase II (86). Although the 15% to 25% 
improvement in patients who have normal exercise capacity 
has lhtle practical impact, patients who have the poorest 
functional capacity are likely to derive the largest benefit 
from exercise training (87). This has significant implications 
for the design of cardiac rehabilitation programs (57,88). 
RehnMtitat~~Tter swgkd mduhrtiw. Rehabilila- 
tion after coronary bypass surgery has been reviewed (Ss), 
but a brief mention is needed here. A number of studies have 
indicated the efficacy and long lasting results of rehabilita- 
tion. Weiner and others (90) repotted in 1981 that sustained, 
measurable improvements in functional capacity occurred in 
patients who participated in exercise rehabilitation for 36 to 
48 months. Oldridge et at. (91) have demonstrated a signifi- 
eant functional difference that persists in those who pariici- 
pate in exercise rehabilitation for extended periods. Froeli- 
cher and associates (92) showed increased oxygen uptake 
and decreased resting and suomaximal heart rates after 
conditioning regardless of whether revascularization ap 
peared complete or incomplete. This finding has implications 
regarding the efficacy of rehabilitation for incompletely 
revarcularized patients regardless of the technique em. 
ployed. 
Rehabiliition after coronary angioplasty. Functional ca- 
pacity has been improved with cardiac rehabilitation after 
coronary angioplasty, but this improvement may represent 
simple conditioningafter reliefofischemic symptoms (93). 1s 
exercise rehabilitation supertluous for those undergoing suc- 
cessful angioplasty? Ben-Ari and colleagues (93a) reported 
significant differences in work capacity and favorable 
changes in low and high density lipoproteins in those partic- 
ipating <6 months in a comprehensive rehabilitation pro- 
gram. Participation had no influence on the rate of restenosis 
(30% vs. 32%), however. or on the incidence of subsequent 
coronary bypass (5% vs. 4.4%) and myocardial i&rction 
(1.6% vs. 1.4%). Despite these findings, Ho:ta (94) sanc- 
tioned the usA of rehabilitation after anp;oulasty in the 
Health Technology Assessment Report pubhshed-in 1991. 
Contributing factors for his recommendation included the 
observation that the rate of return to work after angioplasty 
was disappointingly low, although tine patients were phyri- 
tally capable. (The low rate may be related to rhe Frsis- 
:ence of the “sick role.“) In addition. he recognized that 
patients undergoing angioplasty may have previously dam- 
aged the myocardium or could not be completely revascu- 
larized. The indications for rehabilitation and stratification of 
risk apply regardless of the intervention. High risk patients 
will potentially benefit most, low risk patients the least and 
“patients with intermediate risk and functmn will tikely 
benefit but may not require the full I? weeks of participa- 
tion” (94f, 
Implications for the Future 
Surveilhnre after augioplasty versus a&r myorardial in- 
far&n. The monality rate associa~~J with acute myocar- 
dial infarction has improved greatly during ihe last 2S years. 
but the 1980s were especially significant because of the 
introduction of intravascular thrombolysis (95). In the ma- 
jority of cases, mortality after thrombolysis has dropped to 
3%. making a further reduction in mortalitv hard to obtain 
with newer t eatment strategies. Will this have au impact on 
subsequent thortality and the likelihood that rehabilitation 
can reduce mortality even more? 
Thrombolysis is producing more survivors of myocardial 
infarction who are left with variable amounts of healthy 
myocardium. As Muller and TopI have noted (95). the 
extension of these findings into the subset of patients >70 
years old has significant implications. Patients who previ- 
ctusly wouid have died are now going to be referred for 
rehabilitation as high risk candidates; those who would have 
been at high risk may now be at intermediate or low risk, and 
all will require aggressive modification of coronary disease 
risk factors to attenuate or reverse the progression of their 
coronary artery disease. 
Patients who do nut have recanalization after thrombo- 
lytic therapy have a poor clinical outcome (%I. Interven- 
tions are performed increasingly IO restore patency of large 
infect-related vessels. Moreover, persistent ischemia in 
areas identified as potentially significant after myocardial 
infarction is likely to necessitate interventional or surgical 
revascularizatian. On this basis, fewer patients in rehabiii- 
tation are apt to experience improved mortality on the basis 
of less myocardium at ischemic risk. Angioplasty is ass&. 
ated with a high incidence of failure (97). however. and, if 
anything, phase II rehabilitation provides the kind of close 
supervision in which such failures can be detected early. 
Although low level exercise thallium testing is useful in 
identifying the high risk patient after acute myocardial 
infarction, nearly half of the events after discharge are not 
predicted by low level exercise thallium testing before 
discharge in patients wco receive thmmbolytic ftherapy for 
act-tc myocardial infarction (981. 
The detection of resrenosis after successful coronar; 
angioplastv can bc improved with the use of a logistic model 
that combmes proceduml and follow-up variables (99). Us- 
ing logistic discriminant analysis, Renkin and col!eagues (99) 
developed a model for the prediction of restenosis. Recur- 
rence of angina and exercise ST segment depression. both 
eminently observable phenomena with ECG monitoring and 
medical surveillance in the rehabilitation setting, were sig. 
miicant indicators for the recurrence of stenosis (99). 
secondmy risk nrodlficatioa: vein g&t athwarckrosis amB 
restenosis after aag+asty. Interventional therapies for cor- 
onary artery disease are not curative but are temporary 
measures (100-104). The proportion of patients returning for 
p. second and even a third coronary bypass operation con- 
tinues to increase (105). 
The traditional approach to secondary prevention of 
coronary artery disease is based on one to one professional 
counseling to help patients modify risk factors rhar promote 
progression of the disorder (106). A collective recognition of 
the need for prevention is occurring at a rime when impend- 
ing economic scarcity impels us to anticipate the ewrmous 
financial burden of providing such counseling and supeni- 
sion to the huge group of people who require guidance to 
alter their life-style in a serious and meaningful way (107). 
Recognition of the risk factors for cornnary artery dis- 
ease dates to the Framingham Study (108.109) in the I!%& 
The effectiveness of cholesterol lowering for primary 
prevention of coronary heart disease has heen suggesested 
(103.107.I10. I1 I). Secondary prevention of atherosclerosis 
involves amelioration of the same risk factors (hut afier an 
acute event such as a heart attack or bypass surgery). 
Aggressive treatment of hypercholesterolemia can slow 
and probably even reverse the pmgressionof atherosclerotic 
lesions <I 1 I-l 13). Recent data suggest that life-style inter- 
vention alone, including exercise. diet and psychologic ad- 
aptation without cholesteml-lowering drugs, can arrest or 
reverse coronary atherosclerosis (I 14). Most important, 
such approaches can be targeted successfully toward pa- 
tients who already have demonstrated major manifestations 
of the disease (11s). 
Whether cardiac rehabilitation can reduce COI'O~NY risk 
factors remains controversial (82). Although we believe that 
Kallio et al. (I 16) have demonstrated the efficacy ofcompre- 
hensive rehabilitation for the postmyocardial infarction pa- 
tient. Hedback et al. (ll7l have shown its eft%acy for the 
reduction of multiple risks after coronary bypass surgery. 
and Or&b et al. (I 14) have shown its potential for patients 
who have obstructive athemsclerotic disease. 
Expanded indications: arrhyttrmia, valve t’@aCement ati 
head failure. The incidence of congestive hean failure is 
about 5OO,wO cases/year in the U.S., and the prevalence is 
about 2.5 million (118). With improved therapy such as 
ylgiotensin-converting~ozyme inhibitors, home dobutamine 
therapy and others, we can expect that deaths from cardiac 
failure will continue to decrease and that more patients 
afflicted with this problem will enroll in group programs and 
be appmpriate candidates for home exercise therapy (119). 
Although the number of patients who receive a cardiac 
transplant is small (+,SOa/year), because ofthe severe level 
of deconditioning by the time of the transplant procedure, 
vitiually ail these p&ems are rehabilitation candidates. The 
newer investigational procedure of myocardial myoplasty, 
still in its infancy, requires rehabilitative therapy for the 
framing of the transpositioned latissimus dorsi muscl?. Pa- 
tients who are candidates for this procedure are similar to 
those who are transplant candidates and require significant 
reconditioning. 
ImplantabIe cardioverter-defibrillators that manage lethal 
arrhythmias have been successfully applied. particularly 
since the publication (120) of findings that drugs prescribed 
to suppress lethal or potentially letha! arrhythmias may 
cause more deaths than they prevent. These defibrillators, 
limited initially to patients with a history of sudden death, 
new are being placed increasingly in patients with suscepti- 
ble cardiac substrate and ventricular dysfunction (121) in 
whom sustained ventricular tschycardia can be induced in 
the elcctrophysiology laboratory (122). More than 300,000 
people/year sustain sudden cardiac death: a significant uum- 
ber of survivors will receive one of these implantahle de- 
vices. These patients benefit from exercise (88) and have 
extraordinary needs for psychosocial support that can be 
met in the group environment of the phase II rehabilitation 
program (123). 
On the one hand, the incidence af rheumatic heart disease 
is declining: on the other, the number of mitral valve repair 
procedures for myxomatous valve degeneration is increasing 
and aottic valve stenosis is also on the increase as an 
age-correlated problem (124). Although valvular heart dis- 
ease affects far fewer patients than the number who undergo 
coronary bypass surgery, combined coronary bypass and 
valve procedures are becoming increasingly common (125). 
Although the majority of patients who enroll in cardiac 
rehabifitation have coronary heart disease, as the emphasis 
shifts toward higher risk patients in monitored programs, 
patients with heart failure, a heart transplant, cardiotnyc- 
plasty, serious arrhythmias and an implanted device will 
constituie a larger minority of the participants (88). 
Quality of life, a modern end puink Quatity of life has 
become an increasingly prominent issue in cardiology and 
cardiovascular surgery during the last decade (126). AI- 
though interest has been focused on the high cost of therapy 
(coronary artery bypass surgery and interventional vs. med- 
ical management) (127). every therapy, regardless of its 
expense, now is regarded in the same way. Cardiac rehabil- 
itation is no exception, and, as measutes ofq~ality become 
better understood and more standardized, it will be more 
closely scrutinized (i28). 
Our experience is that cardiac rehabilitation makes a 
significant difference in perceived quality of life. Many 
participanls unquestionably enjoy and value their rehabilita- 
tion program, hut does it make a measurable difference? 
Possibly not, according to Oldridge et al. (129) in a study c 
which disease-specific and generic health-related quality of 
life measures, inctttding exercise tolerance and return to 
work after acute myocarditi infarction. were examined in 
low risk patients who underwent brief rehabilitation. In 
virtually all cases, no di3erences were observed hetw,:en 
those patients who participated in rehabilitation and tb ‘se 
who received usual care (129). 
Wenger (130) notes that the goal of therapy in patients 
with severe symptomatic heart failure is to lessen symptoms 
and maintain functional abitities and comfort and that hemo- 
dynamic features of heart failure (such as ejection fraction) 
are generally not well correlated with quality of life at- 
tributes. Low risk patients wilt probably recover normal 
performance of routine activities of daily living regardless of 
whether they participate in an exercise rehabilitation pro- 
gram. Rehabilitation is less likely to alfect their perception of 
quality of life. For a person who is severely limited, how- 
ever, even modest improvement will probably havea notice- 
able impact on functional capacity (131). It is ironic that 
patients with severely reduced exercise tolerance were for- 
merly excluded from exercise rehabilitation on the arrump- 
tion that they would derive little tangible benefit, defined as 
large, incremental measures in exercise function. 
Oldridge and Rogowski (132) also recently looked al the 
efficacy of ward ambulation versus exercise in specialized 
centers for patients in phase I rehabilitation., Self-efficacy 
variables were measured at various interv& after the event 
up to 28 days after discharge. For the majority of self- 
efficacy variables, both approaches were equally effective. 
As discussed earlier in this chapter, historically. and for 
many institutions today, ward ambulation is the exercise 
mode of choice for inpatient care. 
Reenomic evaluatitm of card& rehrbililali4m services. 
The study of Oldridge and Rogowski (132) raises the ques- 
tion of cost-effectiveness of rehabilitation. The financial 
impact of cardiac rehabilitation services was infrequently 
studied (133) until recently. As Dennis (134) has painted out. 
cost effectiveness and cost-benefit considerations seem es- 
pecially important in cardiac rehabilitation where little short- 
term impact but important potential long-term benefit on 
mortality, disability and psychologic well-being are ex- 
pected. 
Coors Industries (135) estimated recently that they save 
$6 for every $i spent on their comprehensive welltress 
program, which includes mandatory cardiac rehabilitation 
for those employees who experience an acute coronary 
event. Picard and associates (L36) examined ihe impact of 
rehabilitation on earned income and medical care costs and 
found that those persons who receive rehabilitation have 
higher earned iucomes in the 6 months after an acute 
coronary event and generate $500 less in medical care costs. 
Ades et al. (137) found substantial differences in per capita 
hospitalization charges for those participating in rebabilita- 
tion versus nenpartici~nts and dropouts. This was a conse- 
quence of a lower incidence of hospitalization and lower 
charges per hospitalization. However, the study was not 
randomized and did not include the expense of rehabilitation 
as part of the economic analysis, and it did not include 
sayings related to reduced physician services. Prospecrive. 
randomized trials are much needed lo clarify lhis important 
issue. 
Approximately I million peop!e in the U.S. survive an 
acute myoeardial infarction annually (I 151: approximately 
10% to IS?& of these patients subsequently are followed up in 
supervised outpatient cardiac rehabilitation programs (138). 
Assuming that supenised rehabilitation costs about $1 .gOO 
per patient, the annual cost of supervised cardiac rehabilita- 
tion is approximately $200 million. To make informed and 
appropriate dentstons about the allocation of limited re- 
sources to various cardiovascular care services. compam- 
tive economic evaluation must be performed (t39-141). 
Cmt-cfMtveness nnd eont-beaeftt and cost-utility analyses. 
Economic evaluation may be defined as the comparative 
analysis of alternative courses of action in terms of both 
costs and consequences (141). “Costs” usually refers to the 
direct costs borne by health care providers and by the 
patient, whereas “consequences” include effects of the 
intervention, such as changes to the physical. social and 
emotional functioning of patients (142). Ecanomic eralua- 
lions arc classified according to the way in which conse- 
quences are measured in the analysis (140,1411. In cost- 
benefit analysis, consequences are measured in terms of 
dollars; in cost-effectiveness analysis, consequences are 
measured in terms of natural units. such as life-days or 
lif~years gained; and In cost-u!ility aualysir, conreqnrnces 
are measured in qunlitv-adjusted life-years (QALYs). which 
can be estimated by using the time trade-off technique (143131. 
Oldridge and cGtvestigators (I291 included economic 
evaluation in the design of a randomized clinical trial of 8 
weeks ofcomprehensive cardiac rehabilitation initiated after 
acute myocardial infarction. Patients with mild to moderate 
in-hospital anxiety or depression after acute mymardiat 
infarction were randomly assigned to either rehabilitation or 
usual care. Outcomes, including health-related quality of life 
measured by time trade-off scorns. were determined before 
and after the S-week comprehensive cardiac rehabilitation 
infervention and again 4.8 and I2 months later. By the end 
of the trial, cardiac rehabilitation patients had gained 19 
quality-adjusted life-days CO.052 QALYsI per patient over 
usual care patients and made fewer other rehabilitation visits 
during the fottow-up period of the trial (142). 
The investigators then performed cost-utility and cost- 
effectiveness analysis dmine the I-year study usina life- 
years pained estimates from oreviouslv oubhshed meta- 
I - . . 
analyses of cardiac rehabilitation (53.83). The best estimate 
of net-direct l2month costs (1991 U.S. dollars) for patients 
receiving cardiac rehabilitation after acute myocatital infare- 
tion was Wpatient with a cost-utility per quality-adjusted 
ltfe-year gained of $9,200 over the year of fnllow-up. Using 
the reduced 3-year mortality from the meta-analyses or 
cardiac rehabilitaticn (53.93) and quality of liedatafrom the 
present trial, the cost-effectiveness of cardiac rehabilitation 
after acute myocardial infarction was fZt,SOD per life-year 
gained. wnh an estimated cost-utility ratio of %,gM) per 
quality-adjusted life-year gamed, establishing it as a more 
efficient use of resources than most treatments for coronary 
artery disease for which we have cost-utihty estimates. 
A brief office visit for smoking cessation (144), a daily 
aspnin for reducing the incidence of myocardial infarction 
(145). and beta-admnmgic antagonist therapy in a S-year 
old man C 146) are considerably more cost-effective than is 
cardiac rehabilitation. At $21,800 per &year gained, the 
cost-effectiveness of cardiac rehabilitation is similar to that 
of propnnolol for hypertension (blood pressure 34 mml 
Hg\ (1471 and lovaslatin (40 mgldayl for hypercholesterol- 
emia (cholesterol >272 mg!dl) (148f, but considerably more 
cost-effective than captopril for diastolic hypertension 
(blond pressure 294 mm HaI (147) or lovastatin IsO mglday) 
for hypercholesterolemia (cholestemt ~-272 mgldt) (1481. 
The cost-utility estimate of b.200 per quality-adjusted 
life-year was considerably lower than that for single-vessel 
bypass surgery or for treatment of diastolic hypertension 
(blood pressure >94 mm Hg) in a &year old man and was 
similar to the estimate far bypass surgery in patients with left 
main vessel disease (149). These ccmmmic data provide 
some important preliminary evideuce that cardiac rchabili- 
tation after acute myocardiat infarction is an efficient use of 
he&h care rcsourccs and can be economicaily justified. 
Conelusinm. Cardiac rehabilitationhas evolved as a ther- 
apy frcm the ten!a!ive empiricism of clinicians who pm- 
scribed progressively earlier ambulation in their patients 
after acute myoca&d infarction. Its value in reducing 
morbidity and mortality remained in doubt for years, al- 
though it became accepted increasingly for the subjective 
improvement repotted by patients. Ironically, its impact on 
traditional end points became moot in recent years with the 
advent of therapies that vsstty decrease morbidity and 
mortality. Cardiac rehabilitation provides the ideal environ- 
ment for supervising patients closely and for detecting early 
any destabilization after an interventionat procedure. Pa- 
tients who were formerly excluded from exercise training, 
such as those with significant left ventricular dysfunction, 
derive the greatest relative benefit from such training. Risk 
stratification provides a rational rnechanfsm for determining 
appropriate need for cardiac monitoring and for professional 
supervision during exercise. The programs have become 
increasingly important as a means to mo lify coronary risk 
factors throughexerciseand education promoting behavioral 
change. Recent studies suggest th3t cardiW rehabilitation is 
economically sound. 
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